Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us
  • Log in to HL Account

DaVita Inc (DVA) Common Stock USD0.001

Sell:$83.57 Buy:$83.58 Change: $3.64 (4.17%)
Market closed |  Prices as at close on 4 August 2020 | Switch to live prices |
Sell:$83.57
Buy:$83.58
Change: $3.64 (4.17%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 4 August 2020 | Switch to live prices |
Sell:$83.57
Buy:$83.58
Change: $3.64 (4.17%)
Market closed |  Prices as at close on 4 August 2020 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

Contact details

Address:
2000 16th St
DENVER
80202-5158
United States
Telephone:
+1 (310) 5362668
Website:
https://www.davita.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DVA
ISIN:
US23918K1088
Market cap:
$10.64 billion
Shares in issue:
121.98 million
Sector:
Health Care Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Pamela Arway
    Independent Chairman of the Board
  • Javier Rodriguez
    Chief Executive Officer, Director
  • Joel Ackerman
    Chief Financial Officer, Treasurer
  • John Winstel
    Chief Accounting Officer
  • James Hearty
    Chief Compliance Officer
  • LeAnne Zumwalt
    Group Vice President, Government Affairs
  • Kenny Gardner
    Chief People Officer - DaVita Kidney Care
  • Kathleen Waters
    Chief Legal Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.